Biopharmaceutical Manufacturing is a sophisticated process essential for producing Therapeutic drugs and Biologics derived from living organisms. This intricate and highly regulated procedure involves the cultivation of cells, typically bacteria, yeast, or mammalian cells, to express proteins with therapeutic properties. The biopharmaceutical manufacturing pipeline includes fermentation or Cell culture, purification, and formulation steps. As opposed to traditional chemical drug manufacturing, this approach harnesses the cellular machinery to produce complex molecules such as monoclonal antibodies or recombinant proteins. The careful control of environmental conditions and quality parameters is crucial throughout the process to ensure the safety, efficacy, and consistency of the final product. Biopharmaceutical manufacturing plays a pivotal role in supplying medications for a range of diseases, from cancer to autoimmune disorders, contributing significantly to the advancement of modern medicine. The field continues to evolve with innovations in bioprocessing technologies, driving improvements in efficiency, scalability, and the production of novel therapeutic agents.